(Q38152310)

29 August 2017

Latest developments in the biology and management of uveal melanoma (English)

1 reference

29 August 2017

Sapna P Patel

1

1 reference

29 August 2017

1 December 2013

1 reference

29 August 2017

Current Oncology Reports

1 reference

29 August 2017

15

1 reference

29 August 2017

6

1 reference

29 August 2017

509-516

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-013-0348-y

29 August 2017

0 references

cites work

Uveal melanoma: trends in incidence, treatment, and survival

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Occupational risks for uveal melanoma results from a case-control study in nine European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Sunlight exposure and pathogenesis of uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

The biology and management of uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Treatment of primary intraocular melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Uveal melanoma: proton beam irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Epidemiology and management of uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Very long-term prognosis of patients with malignant uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Molecular pathology of uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Lack of BRAF mutation in primary uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Mutations in GNA11 in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Uveal melanoma. Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

The pathology of ocular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Nonrandom chromosomal abnormalities in primary uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Prognostic implications of monosomy 3 in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Association between gene expression profile, proliferation and metastasis in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Frequent mutation of BAP1 in metastasizing uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Insulin-like growth factor-1 as a predictive biomarker for metastatic uveal melanoma in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Surveillance options for patients with uveal melanoma following definitive management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Regression of Ocular Melanoma Metastatic to the Liver After Hepatic Arterial Chemoembolization With Cisplatin and Polyvinyl Sponge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Phase II evaluation of temozolomide in metastatic choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Ipilimumab activity in advanced uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

A phase II study of gefitinib in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

A pilot study of sunitinib malate in patients with metastatic uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Inhibition of mutant GNAQ signaling in uveal melanoma induces AMPK-dependent autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Interleukin-2 therapy for metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0348-Y

Lack of BRAF mutations in uveal melanoma

21 January 2018

1 reference

12 December 2020

Serum markers to detect metastatic uveal melanoma

1 reference

12 December 2020

Prognosis in metastatic choroidal melanoma

1 reference

12 December 2020

Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi

1 reference

12 December 2020

Ocular melanoma metastatic to the liver: the role of surgery in multimodality therapy

1 reference

12 December 2020

Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens

1 reference

12 December 2020

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).

1 reference

12 December 2020

Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis

1 reference

12 December 2020

Posterior uveal melanoma in young patients treated with proton beam therapy

1 reference

12 December 2020

The dynamics of serum tumor markers in predicting metastatic uveal melanoma (part 1)

1 reference

12 December 2020

Absence of BRAF and NRAS mutations in uveal melanoma

1 reference

12 December 2020

The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology

1 reference

12 December 2020

Long-term survival of uveal melanoma patients after surgery for liver metastases

1 reference

12 December 2020

10.1007/S11912-013-0348-Y

Identifiers

DOI

1 reference

PubMed ID

24122445

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

24122445